Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo
Authors
Keywords
Nano-carriers, Ovarian cancer, Paclitaxel, Tumor targeting, Folic acid
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-15
DOI
10.1186/s13046-018-0700-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Biological Cleavage of the C–P Bond in Perfluoroalkyl Phosphinic Acids in Male Sprague-Dawley Rats and the Formation of Persistent and Reactive Metabolites
- (2017) Shira Joudan et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Improved Tumor Uptake by Optimizing Liposome Based RES Blockade Strategy
- (2017) Xiaolian Sun et al. Theranostics
- Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer
- (2016) Miriana Hijaz et al. BMC CANCER
- In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin
- (2016) Merlis P Alvarez-Berríos et al. International Journal of Nanomedicine
- Anti-transferrin receptor-modified amphotericin B-loaded PLA–PEG nanoparticles cure Candidal meningitis and reduce drug toxicity
- (2015) Xiaolong Tang et al. International Journal of Nanomedicine
- Enhanced effect of photodynamic therapy in ovarian cancer using a nanoparticle drug delivery system
- (2015) ZHAO LI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
- (2015) Andreas Wicki et al. JOURNAL OF CONTROLLED RELEASE
- RETRACTED ARTICLE: Targeted immune therapy of ovarian cancer
- (2014) Keith L. Knutson et al. CANCER AND METASTASIS REVIEWS
- Decationized polyplexes as stable and safe carrier systems for improved biodistribution in systemic gene therapy
- (2014) Luís Novo et al. JOURNAL OF CONTROLLED RELEASE
- Colloidal nanoparticles as advanced biological sensors
- (2014) P. D. Howes et al. SCIENCE
- Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review
- (2014) Claudia Marchetti et al. OncoTargets and Therapy
- Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
- (2013) Mark J. Ernsting et al. JOURNAL OF CONTROLLED RELEASE
- "OA02" Peptide Facilitates the Precise Targeting of Paclitaxel-Loaded Micellar Nanoparticles to Ovarian Cancer In Vivo
- (2012) K. Xiao et al. CANCER RESEARCH
- A Folate Receptor-Targeting Nanoparticle Minimizes Drug Resistance in a Human Cancer Model
- (2011) Xu Wang et al. ACS Nano
- Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response
- (2011) Yu-Li Chen et al. Molecular Oncology
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer
- (2010) Ignace Vergote et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Follicle-Stimulating Hormone Peptide Can Facilitate Paclitaxel Nanoparticles to Target Ovarian Carcinoma In vivo
- (2009) X.-y. Zhang et al. CANCER RESEARCH
- Folate-targeted therapeutic and imaging agents for cancer
- (2009) Philip Stewart Low et al. CURRENT OPINION IN CHEMICAL BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More